当前位置:首页 - 行情中心 - 傲农生物(603363) - 财务分析 - 现金流量表

傲农生物

(603363)

  

流通市值:64.18亿  总市值:81.66亿
流通股本:21.47亿   总股本:27.31亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,308,450,133.392,013,020,363.788,211,695,932.755,900,299,153.05
  收到其他与经营活动有关的现金230,701,778.45130,701,853.32576,695,579.41283,053,682.97
  经营活动现金流入小计4,539,151,911.842,143,722,217.18,788,391,512.166,183,352,836.02
  购买商品、接受劳务支付的现金4,154,633,637.271,929,360,176.417,145,739,982.745,323,159,008.48
  支付给职工以及为职工支付的现金370,860,089.46189,022,954.1677,105,229.94494,654,057.87
  支付的各项税费37,243,301.8522,838,403.8978,815,324.5762,069,045.44
  支付其他与经营活动有关的现金305,032,429.76119,987,502.94733,787,562.15594,939,318.38
  经营活动现金流出小计4,867,769,458.342,261,209,037.348,635,448,099.46,474,821,430.17
  经营活动产生的现金流量净额-328,617,546.5-117,486,820.24152,943,412.76-291,468,594.15
二、投资活动产生的现金流量:
  收回投资收到的现金548,583.06548,583.066,171,387.072,250,000
  取得投资收益收到的现金5,687,940.973,611,529.233,041,275.591,087,228.95
  处置固定资产、无形资产和其他长期资产收回的现金净额1,175,944.6965,0964,692,305.32,561,701.7
  处置子公司及其他营业单位收到的现金净额519,834.97-64,593,156.1256,132,093.22
  收到的其他与投资活动有关的现金9,667,377.164,541,975.1614,494,260.272,721,358.56
  投资活动现金流入小计17,599,680.769,667,183.4592,992,384.3564,752,382.43
  购建固定资产、无形资产和其他长期资产支付的现金67,517,399.4341,291,961.95229,897,677.94182,595,112.43
  投资支付的现金260,000200,00010,222,893.256,072,893.25
  取得子公司及其他营业单位支付的现金--389,574.83389,574.83
  支付其他与投资活动有关的现金24,304,115.612,173,841.0323,530,816.289,302,461.88
  投资活动现金流出小计92,081,515.0353,665,802.98264,040,962.3198,360,042.39
  投资活动产生的现金流量净额-74,481,834.27-43,998,619.53-171,048,577.95-133,607,659.96
三、筹资活动产生的现金流量:
  吸收投资收到的现金274,258,6003,860,20031,958,095.918,044,320
  其中:子公司吸收少数股东投资收到的现金5,248,6003,860,20031,958,095.918,044,320
  取得借款收到的现金118,880,000109,000,000297,125,642.83235,327,329.21
  收到其他与筹资活动有关的现金55,700,0001,700,00064,613,109.5348,823,162.47
  筹资活动现金流入小计448,838,600114,560,200393,696,848.26302,194,811.68
  偿还债务支付的现金117,942,603.0987,711,835.35519,825,408.66318,091,161.36
  分配股利、利润或偿付利息支付的现金27,822,104.7713,462,416.2106,971,694.4753,765,626.53
  其中:子公司支付给少数股东的股利、利润15,660,0007,850,00022,465,925.6918,015,925.69
  支付其他与筹资活动有关的现金135,517,884.6171,771,661.94333,648,316.63283,864,300.17
  筹资活动现金流出小计281,282,592.47172,945,913.49960,445,419.76655,721,088.06
  筹资活动产生的现金流量净额167,556,007.53-58,385,713.49-566,748,571.5-353,526,276.38
四、汇率变动对现金及现金等价物的影响-52,372.93-26,317.47-37,603.9-19,425.38
五、现金及现金等价物净增加额-235,595,746.17-219,897,470.73-584,891,340.59-778,621,955.87
  加:期初现金及现金等价物余额546,796,192.81546,796,192.811,131,687,533.41,131,687,533.4
  期末现金及现金等价物余额311,200,446.64326,898,722.08546,796,192.81353,065,577.53
补充资料:
  净利润-271,700,904.73-89,408,894.36-
  资产减值准备--60,942,041.88-
  固定资产和投资性房地产折旧197,508,000.91-396,957,149.95-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧197,508,000.91-396,957,149.95-
  无形资产摊销6,016,236-11,933,252.59-
  长期待摊费用摊销15,317,136.98-27,171,107.63-
  处置固定资产、无形资产和其他长期资产的损失2,355,027.41--359,130.85-
  固定资产报废损失3,745,317.84-3,581,324.26-
  公允价值变动损失580,430-161,130-
  财务费用55,182,758.52-146,889,568.05-
  投资损失-42,134,455.95-28,421,393.24-
  递延所得税3,169,589.49--4,854,895.89-
  其中:递延所得税资产减少3,751,641.47--3,303,142.52-
    递延所得税负债增加-582,051.98--1,551,753.37-
  存货的减少-169,959,722.24--320,175,344.16-
  经营性应收项目的减少-320,410,717.99--435,759,451.43-
  经营性应付项目的增加134,984,914.4--94,149,518.06-
  其他6,507.12--376,782.42-
  债务转为资本97,491,676.75-1,005,937,029.69-
  不涉及现金收支的投资和筹资活动金额其他项目70,999,115.81-79,456,694.41-
  现金的期末余额311,200,446.64-546,796,192.81-
  减:现金的期初余额546,796,192.81-1,131,687,533.4-
  现金及现金等价物的净增加额-235,595,746.17--584,891,340.59-
公告日期2026-08-312026-04-282026-04-232025-10-28
审计意见(境内)标准无保留意见
TOP↑